AFP and hepatocellular carcinoma: Importantly, the effects of high tacrolimus IPV on HCC recurrence remained significant in the fully adjusted model accounting for differences in tumor number, tumor size, microvascular invasion, AFP level, and mean tacrolimus trough concentration.